Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -52.56% is 44% above its 5-year average of -94.66%, near the high end of its 5-year range (-466.78%–-27.82%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.14% above its 12-month average of -58.49%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -52.56%.
RETURN ON EQUITY (ROE)
-52.56%
RETURN ON EQUITY (ROE) AVG TTM
-58.49%
RETURN ON EQUITY (ROE) AVG 3Y
-80.62%
RETURN ON EQUITY (ROE) AVG 5Y
-94.66%
RETURN ON EQUITY (ROE) AVG 10Y
-77.38%
RETURN ON EQUITY (ROE) AVG 15Y
-110.91%
RETURN ON EQUITY (ROE) AVG 20Y
-147.56%
CURRENT VS TTM AVG
+10.14%
CURRENT VS 3Y AVG
+34.80%
CURRENT VS 5Y AVG
+44.47%
CURRENT VS 10Y AVG
+32.08%
CURRENT VS 15Y AVG
+52.61%
CURRENT VS 20Y AVG
+64.38%
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
-39.57%
vs the sector median at left
Capricor Therapeutics, Inc.
Market Cap
$447.43M
Return on Equity (ROE)
-52.56%
TTM Avg
-58.49%
3Y Avg
-80.62%
5Y Avg
-94.66%
Market Cap
$450.64M
Return on Equity (ROE)
-0.01%
TTM Avg
-61.70%
3Y Avg
-96.25%
5Y Avg
-81.28%
Market Cap
$453.70M
Return on Equity (ROE)
-97.92%
TTM Avg
-59.21%
3Y Avg
-49.84%
5Y Avg
-46.25%
Market Cap
$461.55M
Return on Equity (ROE)
8.25%
TTM Avg
6.54%
3Y Avg
3.79%
5Y Avg
3.91%
Market Cap
$428.16M
Return on Equity (ROE)
-70.24%
TTM Avg
-381.56%
3Y Avg
-217.03%
5Y Avg
-155.40%
Market Cap
$468.31M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$471.57M
Return on Equity (ROE)
-9.69%
TTM Avg
-30.79%
3Y Avg
-49.02%
5Y Avg
-53.00%
Market Cap
$416.68M
Return on Equity (ROE)
-54.29%
TTM Avg
-32.16%
3Y Avg
-17.89%
5Y Avg
-29.83%
Market Cap
$478.54M
Return on Equity (ROE)
-24.02%
TTM Avg
-22.16%
3Y Avg
-34.88%
5Y Avg
-37.32%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Capricor Therapeutics, Inc. (CAPR) | $447.43M | -52.56% | -58.49% | -80.62% | -94.66% |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | -0.01% | -61.70% | -96.25% | -81.28% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | -97.92% | -59.21% | -49.84% | -46.25% |
| Kamada Ltd. (KMDA)vs › | $461.55M | 8.25% | 6.54% | 3.79% | 3.91% |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | -70.24% | -381.56% | -217.03% | -155.40% |
| NRC Health (NRC)vs › | $468.31M | 89.43% | 81.07% | 67.39% | 61.90% |
| Cerus Corporation (CERS)vs › | $471.57M | -9.69% | -30.79% | -49.02% | -53.00% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | -54.29% | -32.16% | -17.89% | -29.83% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | -24.02% | -22.16% | -34.88% | -37.32% |
| Carlsmed, Inc. (CARL)vs › | $415.93M | -43.14% | 2.19% | 15.11% | 15.11% |
ROE
-52.6%
ROA
-35.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -52.56% |
| 2026-03-31 | -41.12% |
| 2025-12-31 | -34.35% |
| 2025-09-30 | -97.76% |
| 2025-06-30 | -66.66% |
| 2025-03-31 | -43.14% |
| 2024-12-31 | -27.82% |
| 2024-09-30 | -49.97% |
| 2024-06-30 | -242.96% |
| 2024-03-31 | -131.89% |
| 2023-12-31 | -98.61% |
| 2023-03-31 | -466.78% |
| 2022-12-31 | -246.22% |
| 2022-09-30 | -178.19% |
| 2022-06-30 | -133.75% |
| 2022-03-31 | -92.07% |
| 2021-12-31 | -63.83% |
| 2021-09-30 | -49.03% |
| 2021-06-30 | -53.89% |
| 2021-03-31 | -45.97% |
| 2020-12-31 | -48.43% |
| 2020-09-30 | -36.01% |
| 2020-06-30 | -27.31% |
| 2020-03-31 | -75.13% |
| 2019-12-31 | -111.73% |
| 2019-09-30 | -264.17% |
| 2019-06-30 | -506.01% |
| 2019-03-31 | -375.34% |
| 2018-12-31 | -329.15% |
| 2018-09-30 | 5.34% |
| 2018-06-30 | 18.42% |
| 2018-03-31 | 23.03% |
| 2017-12-31 | 21.65% |
| 2015-09-30 | -594.03% |
| 2015-06-30 | -221.09% |
| 2015-03-31 | -115.80% |
| 2012-12-31 | -38.68% |
| 2012-06-30 | -725.28% |
| 2011-12-31 | -588.04% |
| 2011-09-30 | -169.28% |
| 2011-06-30 | -143.26% |
| 2011-03-31 | -316.28% |
| 2010-12-31 | -232.28% |
| 2010-09-30 | -205.88% |
| 2010-06-30 | -148.67% |
| 2010-03-31 | -541.36% |
| 2009-12-31 | -264.00% |
| 2009-09-30 | -232.96% |
| 2009-06-30 | -583.13% |
| 2009-03-31 | -340.14% |
| 2008-12-31 | -257.31% |
| 2008-09-30 | -169.20% |
| 2008-06-30 | -146.23% |
| 2008-03-31 | -96.16% |
| 2007-12-31 | -67.78% |
| 2007-09-30 | -45.15% |
